Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Prolotherapy for Meralgia Paresthetica
NCT04499911Completed
- Sponsor
- Alexandria University
- Start
- Apr 2018
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial of dextrose in meralgia paresthetica (MP), sponsored by Alexandria University. Primary endpoint: Patient assessment of the overall symptoms of meralgia paresthetica (pain/ burning sensation/paraesthesia) at 4 weeks. Started Apr 2018; status: completed.
02
Drugs
dextrose
03
Conditions
meralgia paresthetica (MP)
Beyond the preview
Go deeper on NCT04499911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499911.